Cargando…

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem

Detalles Bibliográficos
Autores principales: Chebib, Nader, Cottin, Vincent, Taharo-Ag-Ralissoum, Martine, Chuzeville, Michel, Mornex, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022074/
https://www.ncbi.nlm.nih.gov/pubmed/29283031
http://dx.doi.org/10.1177/2045893217753352
_version_ 1783335600380706816
author Chebib, Nader
Cottin, Vincent
Taharo-Ag-Ralissoum, Martine
Chuzeville, Michel
Mornex, Jean-François
author_facet Chebib, Nader
Cottin, Vincent
Taharo-Ag-Ralissoum, Martine
Chuzeville, Michel
Mornex, Jean-François
author_sort Chebib, Nader
collection PubMed
description
format Online
Article
Text
id pubmed-6022074
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-60220742018-07-05 Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem Chebib, Nader Cottin, Vincent Taharo-Ag-Ralissoum, Martine Chuzeville, Michel Mornex, Jean-François Pulm Circ Letter to the Editor SAGE Publications 2017-12-28 /pmc/articles/PMC6022074/ /pubmed/29283031 http://dx.doi.org/10.1177/2045893217753352 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letter to the Editor
Chebib, Nader
Cottin, Vincent
Taharo-Ag-Ralissoum, Martine
Chuzeville, Michel
Mornex, Jean-François
Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
title Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
title_full Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
title_fullStr Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
title_full_unstemmed Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
title_short Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
title_sort epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022074/
https://www.ncbi.nlm.nih.gov/pubmed/29283031
http://dx.doi.org/10.1177/2045893217753352
work_keys_str_mv AT chebibnader epoprostenoldiscontinuationinpatientswithpulmonaryarterialhypertensionacomplexmedicalandsocialproblem
AT cottinvincent epoprostenoldiscontinuationinpatientswithpulmonaryarterialhypertensionacomplexmedicalandsocialproblem
AT taharoagralissoummartine epoprostenoldiscontinuationinpatientswithpulmonaryarterialhypertensionacomplexmedicalandsocialproblem
AT chuzevillemichel epoprostenoldiscontinuationinpatientswithpulmonaryarterialhypertensionacomplexmedicalandsocialproblem
AT mornexjeanfrancois epoprostenoldiscontinuationinpatientswithpulmonaryarterialhypertensionacomplexmedicalandsocialproblem